news
Using a combination of Cas9 and Cas12a, Canadian researchers have…
17 March 2020 | By Victoria Rees (Drug Target Review)
Using a combination of Cas9 and Cas12a, Canadian researchers have enabled CRISPR methods to edit multiple genes at the same time.